Abbott, Merck, Pfizer raising the bar

Share this article:
Abbott Labs stands out as a leader in marketing research, according to a panel discussion at CBI’s 2nd Annual Pharmaceutical Market Research Summit in Philadelphia at the end of April.

“Their business analysts are very personable and you end up with a tight delivery,” said Peter Simpson, president, Segmedica.

 “They are great at integrating information into what they do daily,” added John Tapper, chief strategy officer, Ziment.

Merck was among the large companies given the thumbs-up by the panel. “Merck is a great example of a company getting, and implementing, strategies in the entire space,” said Meredith Abreu, VP at Manhattan Research. “They are very good at getting information out there.”

Pfizer also drew praise. “The brands act like smaller companies,” said Simpson, “so when you go in you are reporting it your way.”

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...